Overview
Vikrant Bhar practices practicing medicine in Haryana, India.
His clinical expertise encompasses Acute Monoblastic Leukemia (AmoL), Anemia, and Graft Versus Host Disease (GvHD).
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Vikrant S. Bhar
Is Vikrant S. Bhar a top-rated expert for Acute Monoblastic Leukemia (AmoL)?
MediFind is an objective health platform that identifies experts based on real-world data. Vikrant S. Bhar is classified as an Experienced expert for Acute Monoblastic Leukemia (AmoL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Vikrant S. Bhar participate in research or clinical trials?
Yes. Vikrant S. Bhar has published 8 articles and abstracts on conditions like Acute Monoblastic Leukemia (AmoL). You can view a list of Vikrant S. Bhar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Monoblastic Leukemia (AmoL)Mr. Bhar isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- AnemiaMr. Bhar isExperienced. Learn about Anemia.
- Graft Versus Host Disease (GvHD)Mr. Bhar isExperienced. Learn about Graft Versus Host Disease (GvHD).